GLP-1s and the Unchanged Moral Narrative of Thinness: A Cultural Analysis
核心洞察
GLP-1 medications for weight loss chemically bypass the need for willpower, yet the cultural narrative equating thinness with virtue and self-discipline persists among users and observers alike.
Historical analysis reveals that across two centuries of weight-loss fads, the underlying assumption—that shrinking the body solves problems unrelated to body size—has remained remarkably unchanged.
Women interviewed about GLP-1 use report that stigma endures: achieving thinness with pharmacological help is perceived as "cheating," and the achievement "doesn't count."
The arrival of GLP-1 receptor agonists (搜索) as weight-loss agents has been framed by some as a paradigm shift—one that rewrites the long-standing cultural narrative tying thinness to psychological discipline and moral virtue. By making appetite suppression a chemical and biological process, these medications ostensibly bypass the need for willpower. Yet a growing body of cultural commentary and feminist analysis suggests that the moralized narrative of thinness has not been dismantled; it has merely been repackaged.
The Mythology of Suffering and Its Chemical Bypass
Across decades, Western culture has relentlessly linked the thinner body to a more controlled, more disciplined self. From the "heroin chic" aesthetic of the 1990s, through the toned empowerment of Victoria's Secret angels, to the "strong is the new skinny" Fitspo movement, the packaging shifted but the core message endured: thinness is the reward for struggle and sacrifice. As one analysis notes, the mythology "acknowledges, almost necessitates, the body's signal of hunger but moralizes the women who can, and cannot, use and optimize it."
GLP-1 medications, originally approved for type 2 diabetes (搜索), entered this cultural milieu with a different promise. By suppressing appetite and slowing gastric emptying, they offered weight loss without the emotional distress of calorie counting and persistent exercise. "Appetite suppression is now advertised as a given chemical and biological phenomena that bypasses the need for psychological discipline and willpower," the analysis observes. Yet the new story still holds that "appetite is a problem, that a suppressed appetite is a liberated one, and that chemical management is care and cure."
The Persistence of Moral Judgment
Despite the pharmacological mechanism, women taking GLP-1s report that the narrative of moralized willpower remains firmly in place. Cassidy George, writing in 032c in 2025, interviewed women on semaglutide. One respondent captured the stigma succinctly: "If you're 'cheating' with Ozempic, then apparently, you don't deserve applause." Another shared, "Skinny was always attractive—it's just easier to reach now. But as soon as people hear you had help getting to the version of yourself that society prefers, it suddenly doesn't count."
George herself described being praised as "the best I had ever looked" during a period when stress and emotional upheaval had left her "profoundly unwell," unable to eat or sleep properly. The cultural gaze, conditioned to equate thinness with virtue, could no longer distinguish wellness from psychological distress.
A Historical Pattern Repeating
This moment fits into a much longer arc. Across two hundred years of weight-loss history—from Lord Byron drinking vinegar to suppress appetite, to amphetamines marketed to housewives, to Fen-Phen prescribed to six million Americans before its withdrawal due to heart valve disease—the methods have changed repeatedly. What has remained "remarkably consistent," one analysis argues, "is the assumption underneath them: that making our bodies smaller is the answer to problems that often have little to do with body size."
Jia Tolentino, writing in 2023, traced thinness as a class and racial signifier from the Industrial Revolution to today, showing how "thinness supremacy is old, adaptive, and persistent." She argues that GLP-1s have ironically "prompted less a public consideration of what it means to be fat than a renewed fixation on being thin." For those using these drugs off-label for aesthetic purposes, Tolentino suggests, "it might function more like an injectable eating disorder (搜索)."
Feminist Critique of Pharmaceutical Marketing
In their 2024 feminist analysis, Warin et al. examined GLP-1 drug advertising's emphasis on women's empowerment. The marketing, they argue, "presents a heroic narrative that unbridles women" by "offering a pharmacological solution that overrides the 'emotional strain of weight loss'" and releasing "women from their time poor lives." Yet the researchers complicate this rhetoric, citing evidence that there is "no guarantee of improved mental health quality of life" after weight loss. They conclude that "a more stable form of self-care" may be best "produced instead through less-conditional self-acceptance."
The Body's Signals and Embodied Self-Knowledge
A deeper concern raised in the cultural analysis involves what is lost when hunger signals are chemically silenced. "The body's signals of hunger and satiety are not simply inconveniences to be managed for those without chronic conditions," the analysis states. "They are, among other things, a form of embodied self-knowledge: the particular knowledge that comes from inhabiting a body over time. What a person knows about their own hunger is part of what they know about themselves."
The historical perspective reinforces this caution. Prolonged undernourishment, regardless of the method producing it, carries harmful biological and psychological consequences. For individuals with a current or past eating disorder (搜索), periods of undernourishment can contribute to the return of eating disorder thoughts, feelings, and behaviors they worked hard to overcome.
Questioning the Goal, Not Just the Method
The broader lesson from two centuries of weight-loss fads is not that GLP-1 medications should be dismissed. They are evidence-based treatments with important medical applications for diabetes and obesity (搜索). Rather, history "asks us to resist assuming that 'new' automatically means 'better' and to keep questioning the beliefs that shape our enthusiasm." Changing the method is not the same as questioning the goal. As one analysis concludes, the shift in perspective can be life-changing: "It is the difference between believing you are broken and recognizing that you were handed a broken premise and asked to make it work."
